BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 34161119)

  • 1. New perspectives of quercetin and vitamin C effects on fibronectin-binding integrins and chemokine receptors in prostate cancer cell lines.
    Amiri A; Abbasi A; Dehghani M; Ramezani A; Ramezani F; Zal F; Mostafavi-Pour Z
    Bratisl Lek Listy; 2021; 122(7):507-512. PubMed ID: 34161119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine receptor expression on integrin-mediated stellate projections of prostate cancer cells in 3D culture.
    Kiss DL; Windus LC; Avery VM
    Cytokine; 2013 Oct; 64(1):122-30. PubMed ID: 23921147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins.
    Engl T; Relja B; Marian D; Blumenberg C; Müller I; Beecken WD; Jones J; Ringel EM; Bereiter-Hahn J; Jonas D; Blaheta RA
    Neoplasia; 2006 Apr; 8(4):290-301. PubMed ID: 16756721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
    Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M
    J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
    Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
    BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization of androgen refractory prostate cancer cells to anti-androgens through re-expression of epigenetically repressed androgen receptor - Synergistic action of quercetin and curcumin.
    Sharma V; Kumar L; Mohanty SK; Maikhuri JP; Rajender S; Gupta G
    Mol Cell Endocrinol; 2016 Aug; 431():12-23. PubMed ID: 27132804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do the expressions of epithelial-mesenchymal transition proteins, periostin, integrin-α4 and fibronectin correlate with clinico-pathological features and prognosis of metastatic castration-resistant prostate cancer?
    Konac E; Kiliccioglu I; Sogutdelen E; Dikmen AU; Albayrak G; Bilen CY
    Exp Biol Med (Maywood); 2017 Dec; 242(18):1795-1801. PubMed ID: 28836852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of epidermal growth factor signal pathway on integrin alpha5 beta1 in prostate cancer cell line DU145].
    Chen HJ; Wang H; Wang QY; Zhang L; Wang GM
    Zhonghua Wai Ke Za Zhi; 2006 Jul; 44(14):966-9. PubMed ID: 17074207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
    Mochizuki H; Matsubara A; Teishima J; Mutaguchi K; Yasumoto H; Dahiya R; Usui T; Kamiya K
    Biochem Biophys Res Commun; 2004 Jul; 320(3):656-63. PubMed ID: 15240098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin can be a more reliable treatment for metastatic prostate cancer than the localized disease: An in vitro study.
    Mirzaei A; Deyhimfar R; Azodian Ghajar H; Mashhadi R; Noori M; Dialameh H; Aghsaeifard Z; Aghamir SMK
    J Cell Mol Med; 2023 Jun; 27(12):1725-1734. PubMed ID: 37232542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of Quercetin and 2-Methoxyestradiol Enhances Inhibition of Human Prostate Cancer LNCaP and PC-3 Cells Xenograft Tumor Growth.
    Yang F; Song L; Wang H; Wang J; Xu Z; Xing N
    PLoS One; 2015; 10(5):e0128277. PubMed ID: 26011145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of integrin subunits, cellular adhesion and tumorgenicity of four human prostate cell lines.
    Witkowski CM; Rabinovitz I; Nagle RB; Affinito KS; Cress AE
    J Cancer Res Clin Oncol; 1993; 119(11):637-44. PubMed ID: 7688749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic properties of prostate cancer cells are controlled by VEGF.
    Chen J; De S; Brainard J; Byzova TV
    Cell Commun Adhes; 2004; 11(1):1-11. PubMed ID: 15500293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin combined with quercetin synergistically repressed prostate cancer cells via inhibition of VEGF/PI3K/Akt signaling pathway.
    Sun S; Gong F; Liu P; Miao Q
    Gene; 2018 Jul; 664():50-57. PubMed ID: 29678660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-β Effects on Prostate Cancer Cell Migration and Invasion Require FosB.
    Barrett CS; Millena AC; Khan SA
    Prostate; 2017 Jan; 77(1):72-81. PubMed ID: 27604827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quercetin modulates Wnt signaling components in prostate cancer cell line by inhibiting cell viability, migration, and metastases.
    Baruah MM; Khandwekar AP; Sharma N
    Tumour Biol; 2016 Oct; 37(10):14025-14034. PubMed ID: 27495232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of Integrin α4 and E-Cadherin Genes in Human Prostate Cancer.
    Mostafavi-Pour Z; Kianpour S; Dehghani M; Mokarram P; Torabinejad S; Monabati A
    Pathol Oncol Res; 2015 Sep; 21(4):921-7. PubMed ID: 25743258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the MIF/CXCR7/AKT Signaling Pathway in Castration-Resistant Prostate Cancer.
    Rafiei S; Gui B; Wu J; Liu XS; Kibel AS; Jia L
    Mol Cancer Res; 2019 Jan; 17(1):263-276. PubMed ID: 30224544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells.
    Hartmann TN; Burger JA; Glodek A; Fujii N; Burger M
    Oncogene; 2005 Jun; 24(27):4462-71. PubMed ID: 15806155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary Flavonoids Luteolin and Quercetin Suppressed Cancer Stem Cell Properties and Metastatic Potential of Isolated Prostate Cancer Cells.
    Tsai PH; Cheng CH; Lin CY; Huang YT; Lee LT; Kandaswami CC; Lin YC; Lee KP; Hung CC; Hwang JJ; Ke FC; Chang GD; Lee MT
    Anticancer Res; 2016 Dec; 36(12):6367-6380. PubMed ID: 27919958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.